Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Gentofte, Denmark.
Department of Cardiology, Heart Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Europace. 2020 Aug 1;22(8):1206-1215. doi: 10.1093/europace/euaa124.
Conflicting results have been reported regarding the effect of beta-blockers on first-registered heart rhythm in out-of-hospital cardiac arrest (OHCA). We aimed to establish whether the use of beta-blockers influences first-registered rhythm in OHCA.
We included patients with OHCA of presumed cardiac cause from two large independent OHCA-registries from Denmark and the Netherlands. Beta-blocker use was defined as exposure to either non-selective beta-blockers, β1-selective beta-blockers, or α-β-dual-receptor blockers within 90 days prior to OHCA. We calculated odds ratios (ORs) for the association of beta-blockers with first-registered heart rhythm using multivariable logistic regression. We identified 23 834 OHCA-patients in Denmark and 1584 in the Netherlands: 7022 (29.5%) and 519 (32.8%) were treated with beta-blockers, respectively. Use of non-selective beta-blockers, but not β1-selective blockers, was more often associated with non-shockable rhythm than no use of beta-blockers [Denmark: OR 1.93, 95% confidence interval (CI) 1.48-2.52; the Netherlands: OR 2.52, 95% CI 1.15-5.49]. Non-selective beta-blocker use was associated with higher proportion of pulseless electrical activity (PEA) than of shockable rhythm (OR 2.38, 95% CI 1.01-5.65); the association with asystole was of similar magnitude, although not statistically significant compared with shockable rhythm (OR 2.34, 95% CI 0.89-6.18; data on PEA and asystole were only available in the Netherlands). Use of α-β-dual-receptor blockers was significantly associated with non-shockable rhythm in Denmark (OR 1.21; 95% CI 1.03-1.42) and not significantly in the Netherlands (OR 1.37; 95% CI 0.61-3.07).
Non-selective beta-blockers, but not β1-selective beta-blockers, are associated with non-shockable rhythm in OHCA.
关于β受体阻滞剂对院外心脏骤停(OHCA)首次记录的心律的影响,已有相互矛盾的结果报告。我们旨在确定β受体阻滞剂的使用是否会影响 OHCA 中的首次记录节律。
我们纳入了来自丹麦和荷兰的两个大型独立 OHCA 注册中心的 OHCA 疑似心源性患者。β受体阻滞剂的使用定义为在 OHCA 前 90 天内使用非选择性β受体阻滞剂、β1 选择性β受体阻滞剂或α-β 双重受体阻滞剂。我们使用多变量逻辑回归计算了β受体阻滞剂与首次记录的心律之间关联的优势比(OR)。我们在丹麦确定了 23834 例 OHCA 患者和 1584 例荷兰患者:7022 例(29.5%)和 519 例(32.8%)分别接受了β受体阻滞剂治疗。与未使用β受体阻滞剂相比,非选择性β受体阻滞剂的使用更常与非可电击节律相关,而非β1 选择性阻滞剂[丹麦:OR 1.93,95%置信区间(CI)1.48-2.52;荷兰:OR 2.52,95%CI 1.15-5.49]。非选择性β受体阻滞剂的使用与更高比例的无脉电活动(PEA)相关,而非可电击节律(OR 2.38,95%CI 1.01-5.65);与停搏的关联相似,尽管与可电击节律相比无统计学意义(OR 2.34,95%CI 0.89-6.18;仅在荷兰有关于 PEA 和停搏的数据)。在丹麦,α-β 双重受体阻滞剂的使用与非可电击节律显著相关(OR 1.21;95%CI 1.03-1.42),而在荷兰则无显著相关性(OR 1.37;95%CI 0.61-3.07)。
非选择性β受体阻滞剂而非β1 选择性β受体阻滞剂与 OHCA 中的非可电击节律相关。